The Adrenal Centre of Excellence

The multi-disciplinary Adrenal Tumour Service at University Hospitals Birmingham (UHB) NHS Foundation Trust has been awarded in the summer 2022 the ‘Centre of Excellence’ status by the European Network for the Study of Adrenal Tumours, ENSAT, an international network dedicated to improving care for patients with adrenal tumours.

The Award of Centre of Excellence status recognises the outstanding contribution of the UHB Adrenal Tumour service to both care and research for affected patients obtaining credits in all the five evaluated domains (or ‘stars’) which relate to areas of adrenal tumour care (including adrenal cancer, aldosterone-producing adenomas, adrenal incidentalomas, pheochromocytoma/paraganglioma), with the fifth star relating to research into causes as well as new tests and therapies for adrenal tumours.

The Adrenal Tumour Service, which is led by UHB’s Endocrine Department, acts for both the local population of 383,000 plus a regional service drawing patients from each of the 4 Cancer Networks which form its regional network of a total population of 3.5 million. Core members of the Adrenal multi-disciplinary team (MDT) include endocrinologists, nurses, surgeons, radiologists, oncologist and pathologists. The team members work closely together to assure the best management and best possible outcome for patients with different types of adrenal tumours. All patients are also offered the opportunity to participate in research, which is carried out in collaboration with national and international networks.